These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11340685

  • 1. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
    Slattery DM, Waltz DA, Denham B, O'Mahony M, Greally P.
    Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
    Durward A, Forte V, Shemie SD.
    Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recombinant human DNase in management of lobar atelectasis due to retained secretions.
    Touleimat BA, Conoscenti CS, Fine JM.
    Thorax; 1995 Dec; 50(12):1319-21; discussion 1323. PubMed ID: 8553310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 8. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep 08; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 9. DNase and atelectasis in non-cystic fibrosis pediatric patients.
    Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ.
    Crit Care; 2005 Aug 08; 9(4):R351-6. PubMed ID: 16137347
    [Abstract] [Full Text] [Related]

  • 10. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb 08; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 11. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
    Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ.
    Pediatr Pulmonol; 2001 May 08; 31(5):377-82. PubMed ID: 11340684
    [Abstract] [Full Text] [Related]

  • 12. Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases.
    Riethmueller J, Kumpf M, Borth-Bruhns T, Brehm W, Wiskirchen J, Sieverding L, Ankele C, Hofbeck M, Baden W.
    Cell Physiol Biochem; 2009 May 08; 23(1-3):205-10. PubMed ID: 19255515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).
    Kamin W, Klär-Hlawatsch B, Truebel H.
    Klin Padiatr; 2006 May 08; 218(2):88-91. PubMed ID: 16506110
    [Abstract] [Full Text] [Related]

  • 17. Where we are now with rhDNase.
    Geddes DM, Shah PL.
    Lancet; 1999 May 22; 353(9166):1727. PubMed ID: 10347981
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M, App EM, Duroux A, Burkert A, Schams A.
    Pulm Pharmacol Ther; 1997 May 22; 10(1):21-7. PubMed ID: 9344829
    [Abstract] [Full Text] [Related]

  • 19. [Perspective of use of rhDNase and new therapeutics for cystic fibrosis].
    Navarro J, Munck A.
    Arch Pediatr; 1995 Jul 22; 2(7):682-4. PubMed ID: 7663661
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.